BRCA2 and ovarian cancer: In Spain, the accumulated risk of developing ovarian cancer before age 70 has been estimated at 22% (95% CI, 0–40%) in carriers of a mutation in BCRA1 and 18% (95% CI, 0–35%) in carriers of a mutation in BRCA2 [44].